Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amikacin”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Testing effectiveness (Phase 2)Study completedNCT04209192
What this trial is testing

Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB)

Who this might be right for
Urinary Tract InfectionsBladder CancerUrologic Surgical Procedures
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 75
Post-approval studies (Phase 4)Active Not RecruitingNCT07694700
What this trial is testing

Colistin and Meropenem Versus Amikacin and Meropenem for MDR Gram Negative Bacteria Regarding Efficacy and Safety.

Who this might be right for
MDR Bacteria
Beni-Suef University 100
Not applicableLooking for participantsNCT02456974
What this trial is testing

Antibiotic Dosing in Pediatric Intensive Care

Who this might be right for
PharmacokineticsAmoxicillin-clavulanatePiperacillin-tazobactam+5 more
University Hospital, Ghent 640
Post-approval studies (Phase 4)Study completedNCT02365272
What this trial is testing

Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department

Who this might be right for
Sepsis
Universitaire Ziekenhuizen KU Leuven 100
Large-scale testing (Phase 3)Study completedNCT02628600
What this trial is testing

Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212

Who this might be right for
NTM Lung Infection Due to MAC
Insmed Incorporated 163
Large-scale testing (Phase 3)UnknownNCT05213507
What this trial is testing

Inhaled Amikacin in Preventing AECOPD

Who this might be right for
COPDCOPD Exacerbation
Shanghai Zhongshan Hospital 136
Not applicableStudy completedNCT02084043
What this trial is testing

In Vitro Assessment of a Breath-synchronized Vibrating Mesh Nebulizer During Non Invasive Ventilation

Who this might be right for
Respiratory DiseasesLung DiseasesCystic Fibrosis+2 more
University Hospital St Luc, Brussels 3
Not applicableStudy completedNCT00129688
What this trial is testing

Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children

Who this might be right for
NeutropeniaCancerFever
Khon Kaen University 166
Testing effectiveness (Phase 2)Study completedNCT01004445
What this trial is testing

Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)

Who this might be right for
Pneumonia
Bayer 69
Not applicableStudy completedNCT04867135
What this trial is testing

Population Pharmacokinetics of Amikacin in Neonates

Who this might be right for
Neonatal Sepsis, Late-Onset
Pontificia Universidad Catolica de Chile 138
Not applicableStudy completedNCT05689450
What this trial is testing

Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder

Who this might be right for
Febrile Neutropenia (FN)
University Hospital, Basel, Switzerland 92
Not applicableUnknownNCT05511129
What this trial is testing

Tolerance and Efficacy of Amiklin Administration During Nosocomial Infections Complicating COVID-19 in the ICU

Who this might be right for
COVID-19Nosocomial Infection
Fondation Hôpital Saint-Joseph 1,053
Large-scale testing (Phase 3)Study completedNCT01799993
What this trial is testing

Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia

Who this might be right for
Pneumonia, Bacterial
Bayer 725
Post-approval studies (Phase 4)Study completedNCT02081963
What this trial is testing

Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis

Who this might be right for
Non-Cystic Fibrosis Bronchiectasis
Qilu Hospital of Shandong University 178
Not applicableStudy completedNCT03683511
What this trial is testing

Nomograms for Optimization of Amikacin First Dose in Critically Ill Patients Using a Population Pharmacokinetics Model

Who this might be right for
Pharmacokinetics
Nantes University Hospital 138
Large-scale testing (Phase 3)Study completedNCT03149640
What this trial is testing

Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia

Who this might be right for
Pneumonia, Ventilator-Associated
University Hospital, Tours 850
Not applicableStudy completedNCT01901497
What this trial is testing

Pharmacokinetics of Nebulized Amikacin in Non Invasive Ventilated Healthy Volunteers.

Who this might be right for
Acute Respiratory InsufficiencyChronic Respiratory InsufficiencyBronchospasm and Obstruction
University Hospital St Luc, Brussels 7
Not applicableStudy completedNCT04322019
What this trial is testing

Prescription Strategies of Amikacin in Intensive Care Patients on Renal Replacement Therapy: an Observational Prospective Multicenter Study

Who this might be right for
Amikacin Treatment
CHU de Reims 112
Testing effectiveness (Phase 2)Study completedNCT00786305
What this trial is testing

Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia

Who this might be right for
Pneumonia
Groupe Hospitalier Pitie-Salpetriere 40
Testing effectiveness (Phase 2)Looking for participantsNCT05730283
What this trial is testing

Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

Who this might be right for
Ototoxicity, Drug-Induced
Kevin Winthrop 105
Next Page